These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13706218)

  • 1. [Chronic obliterating vascular diseases of the periphery in women. II. Arteriosclerosis obliterans].
    GOEBELL H
    Med Welt; 1960 Dec; 52-53():2746-51. PubMed ID: 13706218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral obliterating arteriopathies in their multiple distribution].
    Todini AR; Di Folca A; Paiella ML; Calandra G
    Minerva Cardioangiol; 1998 Oct; 46(10):417-8. PubMed ID: 10021834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic obliterating arteriopathy in view of current pathogenic, clinical & therapeutic orientation].
    MARCOZZI G
    Riforma Med; 1958 May; 72(22):605-11. PubMed ID: 13568484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems in surgery of peripheral obliterating arteriosclerosis. II. Surgical treatment of pain].
    FERRERO R
    Minerva Cardioangiol; 1954; 2(2):91-5. PubMed ID: 13185091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vascular changes in the lumbar sympathetic ganglia in the course of obliterating arterial diseases of the lower limbs].
    MELINA D
    Minerva Chir; 1958 Jan; 13(1):1-8. PubMed ID: 13516620
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of hematopoietic progenitors in bone marrow from patients with peripheral artery disease.
    Muroi K; Kawano-Yamamoto C; Nagashima T; Mori M; Ozawa K; Matsui K; Murakami Y; Ikeda U
    Leuk Res; 2004 Sep; 28(9):999-1000. PubMed ID: 15234580
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic juvenile obliterating arteriopathy].
    BAZAN M
    Sicil Sanit; 1953 Jun; 6(6):411-8. PubMed ID: 13113372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of disopropylammonium dichloroacetate (DIEDI) in the treatment of chronic peripheral arteriosclerotic obliterating arteriopathies].
    GUAGLIANO G; STOPPANI L; VITTORI C
    Minerva Med; 1960 Sep; 51():2931-5. PubMed ID: 13709324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in therapy of obliterating peripheral arteriosclerosis. I. Surgical reestablishment of circulation].
    ENRIA G; FERRERO R
    Minerva Cardioangiol; 1954; 2(1):14-26. PubMed ID: 13176145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alterations of the skeletal musculature and of its vessels in chronic obliterating vascular diseases of the extremities].
    CANDIANI G
    Riv Anat Patol Oncol; 1953 Mar; 6(6):787-812. PubMed ID: 13101428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary changes in artherosclerotic plaques in general arteriosclerosis, hypertension and angioneurosis of the lower extremities].
    RAKHMANOVA LA
    Arkh Patol; 1957; 19(12):29-35. PubMed ID: 13510102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Structural changes of the radial artery in patients with peripheral atherosclerotic arteriopathy].
    Scandale G; Annoni M; Carzaniga G; Colombo F; Carotta G; Orlandi L; Perilli E; Fiorini T; Minola M; Catalano M
    Minerva Cardioangiol; 1999 Dec; 47(12):575-6. PubMed ID: 10670210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of chronic peripheral obliterating arteriopathy. II. Experimental study of the effect of papaverine on the circulation of the extremities].
    BATTEZZATI M; TAGLIAFERRO A
    Minerva Chir; 1954 Nov; 9(22):1072-4. PubMed ID: 14355718
    [No Abstract]   [Full Text] [Related]  

  • 14. Nothing peripheral about this artery disease. New guidelines put the spotlight on the consequences of peripheral artery disease.
    Harv Heart Lett; 2006 Mar; 16(7):1-2. PubMed ID: 19662700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enzymatic inhibition in the treatment of arteriosclerosis obliterans].
    SARGO LF
    Sem Med; 1960 Sep; 117():1079-82. PubMed ID: 13746496
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on arteriosclerosis and endangitis obliterans. VII. Activity of succinoxidase and cytochromoxidase system of skeletal musculare and arteries in peripheral vascular disorders].
    SCHMIDT CG; SCHLIEF H; HILLENBRAND HJ
    Z Gesamte Exp Med; 1955; 125(4):369-78. PubMed ID: 14386905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on arteriosclerosis and endangitis obliterans. VI. The behavior of succinic dehydrogenase in skeletal musculature in peripheral vascular disorders].
    SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1954; 123(6):491-6. PubMed ID: 13196435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tissue histamine levels in some cases of peripheral obliterating arteriosclerosis].
    MANZI G; CILENTO A
    Minerva Chir; 1959 Aug; 14():949-52. PubMed ID: 14420796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histological and histochemical alterations of the sympathetic ganglia in juvenile chronic obstructive peripheral arteriopathies].
    BASSI M; FUSCO A
    Rass Int Clin Ter; 1961 Aug; 41():769-83. PubMed ID: 13687650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on peripheral hematological changes in action in patients with chronic obliterating arterial diseases].
    CASAGRANDE A
    Minerva Chir; 1959 Feb; 14(4):239-42. PubMed ID: 13656576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.